Electra Therapeutics
Health Care · Science & Engineering
4 backers: OrbiMed, Westlake BioPartners, RA Capital Management+1Clinical trials: 3No open roles listed
Data updated Nov 21, 2026Full reportReport a mistake
Lately:9 news stories in 90 daysFollow changes →
Facts
as of Nov 21, 2026The Blueprint for Novel Science. Translating Differentiated Biology into Transformational Medicines.
- Founded
- 2005
- Website
- electra-therapeutics.com
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
Products
Products →Electra Therapeutics has 3 clinical trials on record, 2 under way.
Clinical trials
A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)
phase 1 · under way · 84 participants · T Cell Malignancies
Feb 2026
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
phase 3 · under way · 156 participants · Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
May 2022
Evaluation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ELA026 in Single and Multiple Doses in…
phase 1 · completed · 91 participants · Healthy Volunteers
Oct 2021
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.
Milestones
Sep 9
Founded
2005
Sources: the outlets named on each headline, each story once
What the registers and the postings say about this employer.
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
